Protect Pharmaceutical Corp (OTCMKTS:PRTT) Stock In Focus After Recent Updates
Yesterday, Protect Pharmaceutical Corp (OTCMKTS:PRTT) was in the news cycle after it made some key announcements. The company revealed that it had finally managed to complete the appointment of Ali Yildiz at its President. However, more importantly, it was also announced that it had managed to complete the acquisition of the firm Antarax Capital Danismanlik Limited.
Trading Data
On Monday, PRTT stock decreased 10.25% to $0.7269 with more than 81.62K shares, compared to volume of 20.02K shares. The stock moved within a range of $0.6970 – 0.8025 after opening trade at $0.8000.
Protect Pharmaceutical Corp. Announces New Assets, Leadership and Plans For Full Audit
In addition to that, the company also filed its latest financials with the OTC Markets and claimed that the filings were the mark of the emergence of a whole new version of Protect Pharmaceutical Corp for its shareholders as well as for the public markets at large.
Yildiz had previously been involved in a wide range of acquisitions in the past and in his statement he noted that he was excited with the prospect of moving forward with his plans for Protect Pharmaceuticals.
The completion of the OTC Filings was a major development for the company as well and yesterday, it announced that it was now looking for auditors who would be responsible for completing a full audit of its books. In 2022, Protect had managed to generate revenues in excess of $90 million but in 2023 it expects growth to be modest.
